From scheduling friction to silent financial stress, patient dropout derails trials. Here’s what’s causing it and the tech helping sites fight back.
- RWD Helps Researchers Include More Patients In Lymphoma Research
- RWE Is Ready — Decision Making For Pharmaceuticals Isn't
- Building A Future-Proof, GxP-Compliant IT Infrastructure
- Unlocking Biopharma Innovation With Real-World Evidence
- AI And Clinical Trial Recruitment: Can It Fix The Funnel?
- Elsa's AI Model Migration: Technical, Compliance, And Regulatory Risks For Sponsors (Part 2)
- From Real-World Data To Real-World Impact: Building The Evidence Capability Pharma Actually Needs
- A Clinical Machine Learning Operations (MLOps) Maturity Framework For Biopharma
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Balancing Clinical Care With Digital Utility In Hybrid Trials
To create an effective decentralized clinical trial, tools and methods must be considered within the context of challenges faced by the clinical trial’s patients, physicians, and sites.
-
Patient-Centric Clinical Trials: The Power Of Choice
Patient-centric trials, advocated by the FDA, focus on offering choices to improve engagement, diversity, and data quality. Explore how expanding patient choice can benefit clinical trials.
-
Exploring Integrations In Decentralized Clinical Trials
In this blog, see how each decentralized clinical trial is unique and has its own set of requirements. Based on your trial’s design, consider how to plan for necessary system interactions, leverage the data collected, and select the right partner.
-
From Policy To Practice: PBM Reform, TrumpRx, And Global Drug Development
Policy shifts are reshaping PBM oversight, driving transparent drug‑pricing tools, and influencing global responses that affect affordability, access, and future pharma development.
-
Aligning Wearable Data Collection Tith Visit Schedules Through EDC Integration
Learn how integrating with an EDC system can streamline monitoring and improve data quality in multi-period trials.
-
Leveraging Tech And Clinician Review To Improve Risk Detection
Learn why neuroscience therapy developers should start adopting strategies to improve data quality and assess responses using a combination of technology and expert clinician review.
-
Managing Risk And Regulation In Clinical Trial Technology
Now is the time to evaluate your current risk management framework. Take action today to strengthen your safeguards, tailor your risk assessments, and prioritize transparent patient engagement.
-
Clinical Trial Logistics: Meeting Unique Participant Needs
Uncover why delivering a comprehensive service entails establishing a robust global network equipped with the expertise, resources, and adaptability to address diverse participant needs worldwide.
-
Connected Data For Mission-Critical, Time-Sensitive Moments In A Clinical Trial
Embrace the power of a unified eCOA and IRT platform to drive smarter decisions, ensure data accuracy, and boost efficiency across your studies.
-
Leveraging RWD With AI To Enable Diverse Recruitment In Clinical Trials
A diverse cohort of clinical research participants is vital to developing studies that are representative of the target population. Real-world data (RWD) can be paired with AI to integrate unstructured data.
RECENT NEWSLETTERS
- 04.04.26 -- Your March Briefing: The Best In Clinical Trial Tech
- 04.02.26 -- AI Is Reshaping Clinical Trials: Here's How to Keep Up
- 03.26.26 -- AI, Telehealth & The Tools Reshaping Clinical Trials
- 03.19.26 -- Clinical Trials In 2026: AI, Telehealth & The Platform Shift
- 03.12.26 -- The Future Of Clinical Trials Is Being Built Right Now